These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 36739076)

  • 1. Characterization of the effect of the GLUT-1 inhibitor BAY-876 on T cells and macrophages.
    Chen Z; Vaeth M; Eckstein M; Delgobo M; Ramos G; Frantz S; Hofmann U; Gladow N
    Eur J Pharmacol; 2023 Apr; 945():175552. PubMed ID: 36739076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucose transporter 1 in rheumatoid arthritis and autoimmunity.
    Zezina E; Sercan-Alp O; Herrmann M; Biesemann N
    Wiley Interdiscip Rev Syst Biol Med; 2020 Jul; 12(4):e1483. PubMed ID: 32084302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The glucose transporter Glut1 is selectively essential for CD4 T cell activation and effector function.
    Macintyre AN; Gerriets VA; Nichols AG; Michalek RD; Rudolph MC; Deoliveira D; Anderson SM; Abel ED; Chen BJ; Hale LP; Rathmell JC
    Cell Metab; 2014 Jul; 20(1):61-72. PubMed ID: 24930970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic reprogramming of macrophages: glucose transporter 1 (GLUT1)-mediated glucose metabolism drives a proinflammatory phenotype.
    Freemerman AJ; Johnson AR; Sacks GN; Milner JJ; Kirk EL; Troester MA; Macintyre AN; Goraksha-Hicks P; Rathmell JC; Makowski L
    J Biol Chem; 2014 Mar; 289(11):7884-96. PubMed ID: 24492615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propofol regulates activated macrophages metabolism through inhibition of ROS-mediated GLUT1 expression.
    Zeng W; Xing Z; Tan M; Wu Y; Zhang C
    Inflamm Res; 2021 Apr; 70(4):473-481. PubMed ID: 33751130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose transporter 1-mediated glucose uptake is limiting for B-cell acute lymphoblastic leukemia anabolic metabolism and resistance to apoptosis.
    Liu T; Kishton RJ; Macintyre AN; Gerriets VA; Xiang H; Liu X; Abel ED; Rizzieri D; Locasale JW; Rathmell JC
    Cell Death Dis; 2014 Oct; 5(10):e1470. PubMed ID: 25321477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gout and pseudo-gout-related crystals promote GLUT1-mediated glycolysis that governs NLRP3 and interleukin-1β activation on macrophages.
    Renaudin F; Orliaguet L; Castelli F; Fenaille F; Prignon A; Alzaid F; Combes C; Delvaux A; Adimy Y; Cohen-Solal M; Richette P; Bardin T; Riveline JP; Venteclef N; Lioté F; Campillo-Gimenez L; Ea HK
    Ann Rheum Dis; 2020 Nov; 79(11):1506-1514. PubMed ID: 32699039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor beta-1 upregulates glucose transporter 1 and glycolysis through canonical and noncanonical pathways in hepatic stellate cells.
    Zhou MY; Cheng ML; Huang T; Hu RH; Zou GL; Li H; Zhang BF; Zhu JJ; Liu YM; Liu Y; Zhao XK
    World J Gastroenterol; 2021 Oct; 27(40):6908-6926. PubMed ID: 34790014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting bioenergetics prevents CD4 T cell-mediated activation of synovial fibroblasts in rheumatoid arthritis.
    Petrasca A; Phelan JJ; Ansboro S; Veale DJ; Fearon U; Fletcher JM
    Rheumatology (Oxford); 2020 Oct; 59(10):2816-2828. PubMed ID: 32047926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian Cancer Relies on Glucose Transporter 1 to Fuel Glycolysis and Growth: Anti-Tumor Activity of BAY-876.
    Ma Y; Wang W; Idowu MO; Oh U; Wang XY; Temkin SM; Fang X
    Cancers (Basel); 2018 Dec; 11(1):. PubMed ID: 30602670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promotion of Calcium/Calmodulin-Dependent Protein Kinase 4 by GLUT1-Dependent Glycolysis in Systemic Lupus Erythematosus.
    Koga T; Sato T; Furukawa K; Morimoto S; Endo Y; Umeda M; Sumiyoshi R; Fukui S; Kawashiri SY; Iwamoto N; Ichinose K; Tamai M; Origuchi T; Nakamura H; Kawakami A
    Arthritis Rheumatol; 2019 May; 71(5):766-772. PubMed ID: 30462889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA PVT1 links Myc to glycolytic metabolism upon CD4
    Fu J; Shi H; Wang B; Zhan T; Shao Y; Ye L; Wu S; Yu C; Zheng L
    J Autoimmun; 2020 Feb; 107():102358. PubMed ID: 31757716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glut1 expression is increased by p53 reduction to switch metabolism to glycolysis during osteoblast differentiation.
    Ohnishi T; Kusuyama J; Bandow K; Matsuguchi T
    Biochem J; 2020 May; 477(10):1795-1811. PubMed ID: 32242617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell surface Glut1 levels distinguish human CD4 and CD8 T lymphocyte subsets with distinct effector functions.
    Cretenet G; Clerc I; Matias M; Loisel S; Craveiro M; Oburoglu L; Kinet S; Mongellaz C; Dardalhon V; Taylor N
    Sci Rep; 2016 Apr; 6():24129. PubMed ID: 27067254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diaminobutoxy-substituted Isoflavonoid (DBI-1) Enhances the Therapeutic Efficacy of GLUT1 Inhibitor BAY-876 by Modulating Metabolic Pathways in Colon Cancer Cells.
    Guo L; Zhang W; Xie Y; Chen X; Olmstead EE; Lian M; Zhang B; Zaytseva YY; Evers BM; Spielmann HP; Liu X; Watt DS; Liu C
    Mol Cancer Ther; 2022 May; 21(5):740-750. PubMed ID: 35247917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of GLUT1 and GLUT3 in the growth of canine melanoma cells.
    Suwabe Y; Nakano R; Namba S; Yachiku N; Kuji M; Sugimura M; Kitanaka N; Kitanaka T; Konno T; Sugiya H; Nakayama T
    PLoS One; 2021; 16(2):e0243859. PubMed ID: 33539362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The in vitro effect of the diabetes-associated markers insulin, leptin and oxidative stress on cellular characteristics promoting breast cancer progression is GLUT1-dependent.
    Silva C; Andrade N; Guimarães JT; Patrício E; Martel F
    Eur J Pharmacol; 2021 May; 898():173980. PubMed ID: 33647254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dihydroartemisinin inhibits glucose uptake and cooperates with glycolysis inhibitor to induce apoptosis in non-small cell lung carcinoma cells.
    Mi YJ; Geng GJ; Zou ZZ; Gao J; Luo XY; Liu Y; Li N; Li CL; Chen YQ; Yu XY; Jiang J
    PLoS One; 2015; 10(3):e0120426. PubMed ID: 25799586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of glucose transporter 1 (GLUT1) expression levels alters mouse mammary tumor cell growth in vitro and in vivo.
    Young CD; Lewis AS; Rudolph MC; Ruehle MD; Jackman MR; Yun UJ; Ilkun O; Pereira R; Abel ED; Anderson SM
    PLoS One; 2011; 6(8):e23205. PubMed ID: 21826239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ATM inhibitor KU-55933 induces apoptosis and inhibits motility by blocking GLUT1-mediated glucose uptake in aggressive cancer cells with sustained activation of Akt.
    Harris BRE; Zhang Y; Tao J; Shen R; Zhao X; Cleary MP; Wang T; Yang DQ
    FASEB J; 2021 Apr; 35(4):e21264. PubMed ID: 33715230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.